论文部分内容阅读
小蘗硷目前在医疗上有着广泛的用途,我国以往大多从黃連(包括黄連Coptis chinensis Franch)峨嵋野連C. omeiensis C.Y.Cheng,Mss.;云連(C.teetoides C.Y.Cheng.Mss.)的根莖或黃栢(包括东黄栢Phelledendron amurense Rupr.;川黃栢P.chinense Schneid.)的內皮中提制,但是这二类植物的售价都比較昂貴,並且又都是常用中药,在中药中已經有很大的需用量,因此寻找更为經济,蘊藏量更为丰富的小蘗硷資源植物便具有很大的实际意义。根据文献和资料,我国含小蘗硷的資源植物,主要包括下列的几个科屬:毛茛科(Ranunculaceae)的黄連属(coptis)、白蓬草属(Thalictrmn)、驢蹄草属
Currently, Xiaolan has a wide range of uses in medicine. In the past, most of the Chinese people used Coptis (including Coptis chinensis Franch) and C. omeiensis CYCheng, Mss., and C. Teetoides CYCheng. Mss. Rhizome or Phellodendron chinense (including Phelledendron amurense Rupr.; P.chinense Schneid.) is extracted from the endothelium, but these two types of plants are relatively expensive and are commonly used traditional Chinese medicines. There is a large amount of demand, so looking for a more economical resource with a greater abundance of resources will have great practical significance. According to the literature and data, the resource plants in China that contain S. bracteata mainly include the following families: Coptis, Thapictrmn, and Marshmallow in the family Ranunculaceae.